Friday, 26 April 2024
Sunesis Pharmaceuticals Inc.
NASDAQ : SNSS
5.320 24 Feb 21 00:00 | Change: 1.04 | Open: 4.670 | High: 7.090 | Ask: 4.270 | Volume: 70,211,900 |
Change(%): 24.30 | Prev: 4.280 | Low: 4.670 | Bid: 3.090 | Avg vol: 0 |
Risk Alert: Before we dive into any analysis we simply note that Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) risk is at an extremely elevated level.
more»
09:03 | 15/3/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.
more»
23:52 | 13/3/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the cancellation of the company's presentation and webcast at the Cowen & Company 38th Annual Health Care Conference, previously ...
more»
05:18 | 13/3/18
Market Exclusive
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) hit markets with some disappointing news at the end of last week and has picked up a real slump in its market capitalization on the back of the development.
more»
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) dropped 42.39 percent to close at $4.24 on Friday. Sunesis Pharma reported a Q4 loss of $0.21 per share.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |